• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    VP Acctg and Treasurer Gendenjamts Davaajargal was granted 35,504 shares, increasing direct ownership by 130% to 62,777 units (SEC Form 4)

    6/11/25 7:30:23 PM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Gendenjamts Davaajargal

    (Last) (First) (Middle)
    C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
    BUILDING C, SUITE 310

    (Street)
    ENGLEWOOD CO 80112

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Gevo, Inc. [ GEVO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    VP Acctg and Treasurer
    3. Date of Earliest Transaction (Month/Day/Year)
    06/09/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1) 06/09/2025 A 35,504 A $0 62,777 D
    Common Stock 992.69(2) I By 401(k) Plan
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option $1.18 06/09/2025 A 106,513 (3) 06/08/2035 Common Stock 106,513 $0 106,513 D
    Explanation of Responses:
    1. Represents restricted common stock that vests in three equal annual installments beginning on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
    2. Between December 1, 2024 and June 6, 2025, the reporting person (i) acquired 994.29 shares of the issuer's common stock under the issuer's 401(k) plan, and (ii) disposed of 1.60 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated May 22, 202
    3. The stock options shall vest in three equal annual installments beginning on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
    /s/ E. Cabell Massey, Attorney-in-Fact 06/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GEVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP Acctg and Treasurer Gendenjamts Davaajargal was granted 35,504 shares, increasing direct ownership by 130% to 62,777 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/11/25 7:30:23 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • CFO Agiri Oluwagbemileke Yusuf was granted 189,084 shares, increasing direct ownership by 124% to 341,224 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/11/25 7:30:12 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Chief People and IT Officer Bowron Kimberly T was granted 115,546 shares, increasing direct ownership by 30% to 506,820 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/11/25 7:30:14 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Gevo Promotes Lindsay Fitzgerald to Chief Advocacy and Communications Officer

      ENGLEWOOD, Colo., June 03, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today the promotion of Lindsay Fitzgerald to Chief Advocacy and Communications Officer, effective immediately. In this expanded leadership role, Ms. Fitzgerald will focus on advancing Gevo's mission to strengthen American energy and food security by unlocking the full value of U.S. agriculture and rural communities. She continues to drive policy advocacy and public communications that support cost-effective, American-made hydrocarbon fuels and chemicals, while building free-market solutions for carbon abatement and economic growth. Her efforts help bolster U.S. agriculture as the most sustainable in the

      6/3/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo to Sell Luverne, Minnesota Ethanol Facility to A.E. Innovation; Will Retain Isobutanol Assets for Future Innovation

      ENGLEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that it has entered into a definitive agreement to sell Agri-Energy, LLC ("Agri"), a wholly owned subsidiary of Gevo, to A.E. Innovation, LLC ("A.E.") for $7 million. The transaction includes Agri's 18-million-gallon-per-year ethanol-production facility located in Luverne, Minnesota. Gevo will retain ownership of certain isobutanol-production-related assets and a portion of the vacant land at the site for future use. With these retained assets, Gevo could potentially produce up to 1 million gallons per year of isobutanol, which can be sold as a specialty chemical, or converted into isooctane

      5/28/25 9:00:00 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

      5/27/25 4:10:00 PM ET
      $GEVO
      $GHM
      Major Chemicals
      Industrials
      Industrial Machinery/Components

    $GEVO
    SEC Filings

    See more
    • SEC Form S-8 filed by Gevo Inc.

      S-8 - Gevo, Inc. (0001392380) (Filer)

      6/5/25 7:38:48 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • SEC Form 144 filed by Gevo Inc.

      144 - Gevo, Inc. (0001392380) (Subject)

      6/3/25 4:05:51 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Gevo, Inc. (0001392380) (Filer)

      5/27/25 4:01:41 PM ET
      $GEVO
      Major Chemicals
      Industrials